Continuation of anakinra despite the development of a pruritic rash in an otherwise refractory case of adult-onset Still's disease.
Vordenbäumen
S
S
Ostendorf
B
B
Sander
O
O
Richter
J
J
Schneider
M
M
D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology*; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011537:Pruritus / Q000139:chemically induced*; D012074:Remission Induction; D016706:Still's Disease, Adult-Onset / Q000188:drug therapy*
D018501:Antirheumatic Agents; D053590:Interleukin 1 Receptor Antagonist Protein